February 9, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), ultrafast (UF) MRI provides beneficial information that can be used in surgical planning, including determining the need to perform sentinel lymph node biopsy. 

February 9, 2023 — Onsite Women’s Health, a leading national provider of breast health services, announces partnership with Volpara Health to adopt Volpara Analytics, an artificial intelligence (AI) software tool that improves mammography quality by assessing every mammogram image for appropriate positioning, compression and radiation dose.

February 9, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced the presentation of additional results from its completed Phase 3 LIGHTHOUSE trial of 18F-rhPSMA-7.3 in newly diagnosed prostate cancer, at the upcoming ASCO GU 2023 Genitourinary Cancers Symposium (ASCO GU).

February 8, 2023 — Carestream Health is partnering with Robarts Research Institute to increase and demonstrate the clinical value of digital X-ray, digital tomosynthesis and dual energy technologies to help improve the outcomes of patients with cardiothoracic and pulmonary diseases.

February 8, 2023 — New data published in the Journal of Clinical Oncology further quantify the vast lingering impact of the global COVID-19 pandemic on timely cancer screening, highlighting the urgent need for health care providers to address significant delays to cancer screenings in populations most likely to delay testing. 

February 8, 2023 — Cleveland Clinic researchers have launched the next step in their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.  

February 8, 2023 — Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, introduces the HERA W10 Elite1; the premier model of the HERA platform for Obstetrics and Gynecology that provides clinicians with a suite of powerful artificial intelligence (AI) tools and clinical applications to advance the diagnostic experience. 

February 7, 2023 — During World Cancer Day (February 4), the Elekta Foundation celebrated its first year by highlighting its achievements and coming initiatives to improve access to cancer care in low-income countries.

February 7, 2023 — Primary lung neuroendocrine tumors are very rare tumors that represent about 1-2% of all lung cancer cases. Only 2,000 to 4,500 are diagnosed in the U.S. each year. The common treatment for early stage lung neuroendocrine tumors is surgery, but that is not an option for all patients.

February 7, 2023 — IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology, today announces that it has received the downpayment for a contract signed at the end of December 2022 with the H. Lee Moffitt Cancer Center and Research Institute Hospital (“Moffitt”) in Tampa, Fla., for the installation of its Proteus ONE compact proton therapy system.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now